NeuroMetrix Corp - נכסים נקיים למניה בודדת NURO

NeuroMetrix, Inc. (NURO) develops wearable drug-free pain therapy systems utilizing proprietary Quell technology. GURU.Markets analytics track the book value per share trend, where the current metric stands at 7.03. The growth in fundamental value is driven by the implementation of ESG standards and the reduction of plastic waste, as well as the deployment of automated neurostimulator assembly lines integrated with cloud software.

For NeuroMetrix, Inc., whose innovations in nerve stimulation are constrained by strict FDA regulation and medical conservatism, this indicator serves as a measure of the business's real value. Book value per share is defined as the ratio of equity to the number of issued shares; therefore, analyzing the amount of equity per share allows for an assessment of the company's intrinsic resilience during periods of price stagnation.